TABLE 2.
Parameter | NVLCs | AVMs | p Value* | ||
---|---|---|---|---|---|
Total | Unruptured | Ruptured | |||
Pericyte no. | |||||
PDGFRβ-positive pericytes (per mm2 endothelium) | 2658.1 ± 174.8 | 845.6 ± 47.9† | 844.9 ± 63.8 | 842.8 ± 77.4 | 0.99 |
CD13-positive pericytes (per mm2 endothelium) | 2657.0 ± 140.7 | 862.2 ± 61.4† | 832.3 ± 71.7 | 907.1 ± 114.1 | 0.59 |
Pericyte coverage | |||||
% PDGFRβ-positive pericyte coverage | 81.3 ± 2.3 | 40.6 ± 2.5† | 44.3 ± 3.6 | 35.1 ± 2.0 | 0.04 |
% CD13-positive pericyte coverage | 82.7 ± 2.1 | 39.4 ± 2.8† | 43.9 ± 3.2 | 32.6 ± 3.4 | 0.03 |
Boldface type indicates statistical significance.
Unruptured compared with ruptured AVMs.
All values statistically significant with p < 0.01 when NVLCs are compared with total AVMs.